1. Ö. Arslan, H. Akan, M. Beksaç, O. İlhan, H. Koç, N. Konuk. Terminal deoxynucleotidyl transferase (TdT) positivity in acute nonlymphoblastic leukemia. Leukemia 8(6):1067,1994 .
2. O. İlhan, M. Beksaç, H. Koç, H. Akan, A. Keskin, Ö. Arslan, G. Gürman, M. Özcan, N. Konuk, A. Uysal. HLA-DR frequency in Turkish Aplastic Anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapy. Blood 86:2055, 1995 .
3. Ö. Arslan, H. Akan, H. Koç, M. Beksaç, O. İlhan, M. Özcan, S.Yalçın, G. Gürman, N. Konuk, A. Uysal. Eosinophilia after allogeneic bone marrow transplantation using Busulfan + Cyclophosphamide conditioning regimen. Bone Marrow Transplant 18, 276, 1996.
4. Ö. Arslan, H. Akan, M. Beksaç, M. Özcan, H. Koç, O. İlhan, N. Konuk, A. Uysal. Lack of prognostic value of CD34 in adult AML. Leukemia & Lymphoma 23; 185-186, 1996. ...[Devamı...]
5. G. Gürman, Ö. Arslan, H. Koç, H. Akan. Donor leukocyte infusion for relapsed ANLL after allogeneic BMT and the use of interferon alpha to induce graft versus leukemia effect. Bone Marrow Transplant 18, 825-826 1996.
6. H. Koç, G. Gürman, Ö. Arslan, M. Özcan, H. Akan, O. İlhan, N. Konuk, M. Beksaç, A.Uysal. Is there an increased risk of graft versus host disease after allogeneic peripheral blood stem cell transplantation. Blood 88;2362-2364,1996.
7. H. Koç, Ö. Arslan, G. Gürman, H. Akan, M. Özcan, O. İlhan, İ. Aydoğdu, M. Arat, M. Beksaç, N.Konuk, A.Uysal. The use of high dose chemotherapy plus granulocyte colony stimulating factor for the salvage of refractory or resistant relapse malignant lymphoma patients without stem cell support. Acta Hematologica 98; 136-139, 1997.
8. O. İlhan, H. Koç, H. Akan, G. Gürman, Ö. Arslan, M. Özcan, N. Arıkan, H. Sencer, N. Konuk, A. Uysal, M. Beksaç. Hemorrhagic cystitis as a complication of bone marrow transplantation. Journal of Chemotherapy 9(1):56-61,1997.
9. H. Akan, H. Koç, Ö. Arslan, M. Beksaç, O. İlhan, G. Gürman, M. Özcan, N. Konuk, A. Uysal. Febrile neutropenia in a bone marrow transplantation center. Int J Antimicrobial Agents 8:127-130, 1997.
10. O. İlhan, H. Akan, H. Koç G Gürman, Ö. Arslan, M. Özcan, H. Erdi, C. Erdem, N. Konuk A. Uysal, M. Beksaç. Incidence of graft versus host disease in allogeneic bone marrow transplantation in a single center study from Turkey. Hematology and Cell Therapy 39:133-136, 1997.
11. H. Koç, G. Gürman, Ö. Arslan, M. Özcan, H. Akan, O. İlhan, N. Konuk, M. Beksaç, A. Uysal. Allogeneic peripheral blood stem cell transplantation. Is there an increase risk of GVHD in leukemia paitents. Journal of Chemotherapy 9(5);371-376, 1997.
12. C. Üstün, H. Koç, S. Karayalçın, G. Akyol, G. Gürman, O. İlhan, H. Akan, M. Özcan, Ö. Arslan, N. Konuk, A. Uysal, M. Beksaç. Hepatitis B virus infection in allogeneic bone marrow transplantation. Bone Marrow Transplant 20:289-296, 1997.
13. O. İlhan, M. Beksaç, Ö. Arslan, M. Özcan, H. Koç, H. Akan, G. Gürman, N. Konuk, A. Uysal. HLA DR2: A predictive marker in response to cyclosporine therapy in aplastic anemia. International Journal of Hematology 66;291-295, 1997.
14. Ö. Arslan. Peripheral blood stem cells for allogeneic transplantation: Is it going to replace bone marrow stem cells. Blood Banks Association of New York State Inc. 31(4);10-13, 1997.
15. Ö. Arslan, G. Gürman, İ. Dilek, M. Özcan, H. Koç, O. İlhan, H. Akan, N. Konuk, A. Uysal, M. Beksaç. Incidence of Tuberculosis after bone marrow transplantation in a single center from Turkey. Haematologia 29 (1); 59-63, 1998.
16. Ö. Arslan, A. Seferoğlu, G. Gürman, O. İlhan, H. Koç. Resistant graft failure overcome with allogeneic peripheral blood plus bone marrow stem cells. Haematologia 29 (1); 47-51, 1998.
17. C. Üstün, C. Sungur, O. Akbaş, A. Sungur, Y. Gürgen, Ş. Ruacan, G. Gürman, Ö. Arslan. Spontaneous splenic rupture as the initial presentation of plasma cell leukemia: A case report. American Journal of Hematology 57(3):266-267, 1998.
18. H. Akan, M. Akova, H. Ataoğlu, G. Aksu, Ö. Arslan, H. Koç. Rhodococcus equi and Nocardia brasiliensis infection of the brain and liver in a patient with acute nonlymphoblastic leukemia. Eur J Clin Microbial Infect Dis 17;737-739, 1998.
19. M. Beksaç, Ö. Arslan, H. Koç, H. Akan, O. İlhan, M. Arat, M. Özcan, G. Gürman, N. Konuk, A. Uysal. Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukemia. Medical Oncology 15; 183-190, 1998.
20. Ö. Arslan, C. Üstün, M. Arat, H. Çelebi, H. Akan, M. Beksaç, O. İlhan, G. Gürman, M. Özcan, N. Konuk, A. Uysal, H. Koç. Allogeneic peripheral blood stem cell transplantation in acute nonlymphoblastic leukemia. Hematological Oncology16;155-162, 1998.
21. C. Üstün, Ö. Arslan, M. Beksaç, H. Koç, G. Gürman, T. Özçelik, B. Yılmaz, O. İlhan, H. Akan, M. Özcan, T. Demirer, A. Uysal, N. Konuk, M. Arat, İ. Dilek, H. Çelebi, H.Ş. Coşkun. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center, afocus on the incidence of GVHD and relapse. Biology of Blood and Marrow Transplantation 5;28-35,1999.
22. O. İlhan, Ö. Arslan, M. Arat, M. Beksaç, H. Akan, M. Özcan, G. Gürman, N. Konuk, A. Uysal, H. Koç. The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation. Transfusion Science 20; 69-71, 1999.
23. O. İlhan, N. Üskent, Ö. Arslan, M. Arat, F. Özkalemkaş, G. Öztürk, S. Beşışık-Kalayoğlu, A. Özet, M. Tombuloğlu, M. Arpacı, E. Ovalı, S. Anak. On behalf of Turkish Apheresis Group. National Survey of hemapheresis practice in Turkey (1998). Transfusion Science 22:195-201, 2000.
24. Ö. Arslan, H. Akan, M. Arat, K. Dalva, M. Özcan, G. Gürman, O. İlhan, N. Konuk, M. Beksaç, A. Uysal, H. Koç. Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selektin, sCD44) in healthy allogeneic peripheral blood stem cell donors primed with recombinant granulocyte-colony stimulating factor. Cytotherapy 2 (4) :259-265, 2000.
25. Ö. Arslan, HŞ. Coşkun, M. Arat, H. Çelebi, M. Özcan, G. Gürman, C. Üstün, T. Demirer, H. Akan, O. İlhan, N. Konuk, M. Beksaç, A. Uysal, H. Koç Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of bni Sina Hospital . Bone Marrow Transplantation 25, 1229-1232, 2000.
26. Idilman R, Ustun C, Akan H, Karayalcin S, Ozcan M, Arslan O, Ilhan O, Akyol G, Bozdayi M, Colantoni A, Van Thiel DH, Koç H. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation: Risk and benefit ratio of HBV vaccination in recipients. Hepatology 32: (4) 1181, Part 2 OCT 2000.
27. M. Özcan, C. Üstün, E. Akçağlayan, H. Akan, Ö. Arslan, O. İlhan, M. Beksaç, G. Gürman, T. Demirer, M. Arat, H. Çelebi, N. Konuk, A. Uysal, H. Koç. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 27:499-505, 2001.
28. G. Gürman, M. Arat, O. İlhan, N. Konuk, M. Beksaç, H. Çelebi, M. Özcan, Ö. Arslan, C. Üstün, H. Akan, A. Uysal, H. Koç. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies. Cytotherapy 3(4); 253-260, 2001.
29. G. Aksu, M.Z. Ruhi, H. Akan, S. Bengisun, C. Üstün, Ö. Arslan, H. Özenci. Aerobic bacterial andfungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 27: 201-205, 2001.
30. G. Gürman, İ. Dilek, Ö. Arslan, M. Arat, M. Beksaç, O. İlhan, M. Özcan, H. Akan, K. Dalva, N. Konuk, A.Uysal, H. Koç. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation. Transfusion and Apheresis Science 24 (1): 23-28, 2001.
31. G. Gürman, H. Çelebi, C. Üstün, M. Arat, O. İlhan, M. Özcan, Ö. Arslan, A. Uysal, H. Akan, M. Beksaç, N. Konuk, H. Koç. Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia. Therapeutic Apheresis 5(1); 54-57, 2001.
32. M Çetin, B. Eser, Ö. Er, A. Ünal, E. Kılıç, T. Patıroğlu, H.S. Çoşkun, M. Altınbaş, Ö. Arslan, O. İlhan. Efffects of DMSO on platelet functions and P-selectin expression during storage. Transfusion and Apheresis Science 24(3):261-7, 2001
33. M. Arat, Ö. Arslan, M. Beksaç, K. Keven, G. Nergisoğlu, Ş, Ertürk. Hematopoietic transplantation related nephropathy. Am J Kidney Disease 38; 218-219, 2001.
34. T. Demirer, O. İlhan, M. Arat, Y. Genç, M. Özcan, K. Dalva, H. Çelebi, M. Beksaç, H. Akan, G. Gürman, N. Konuk, A. Uysal, Ö. Arslan, H. Koç. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. J of Clinical Apheresis 16; 67-73, 2001.
35. T. Demirer, M. Aylı, M. Özcan, M. Günel, R. Haznedar, M. Dağlı, T. Fen, S. Dinçer, Ö. Arslan, G. Gürman, S. Demirer, G. Özet, A. Uysal, N. Konuk, O. İlhan, H. Koç, H. Akan. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. Br J Haematol. 2002 Feb;116(2):468-74.
36. S. Kutlay, O. İlhan, Ö. Arslan, M. Beksaç. Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers. Ther Apher Feb 6(1):182-85, 2002
37. T. Demirer, M. Dağlı, O.İlhan, M. Aylı, R. Haznedar, T. Fen, N. Günel, Y. Genç, M. Arat, M. Özcan, Ö. Arslan, E. Seyrek, S. Dinçer, T . Üstün, N. Ustael, H. Koç, O. Muftuoğlu, H. Akan. A randomized trial of assesement of efficacy of leukapheresis volumes, 8 liters vs 12 liters. Bone Marrow Transplant 29;893-897, 2002.
38. T. Demirer, O. İlhan, M Aylı, M. Arat, M Dağlı, M. Özcan, R. Haznedar, Y. Genç, T. Fen, E. Ayyıldız S. Dinçer, Ö. Arslan, G. Gürman, N. Konuk, K. Dalva, A. Uysal, H. Koç. G. Özet, H. Akan. Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficicient cell yield. Therapeutic Apheresis 6(5):284-389, 2002.
39. İ. Tek, Ö. Arslan, M. Arat, M. Özcan, B. Akbağ, O. İlhan. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange. Transfusion and Apheresis Science 28; 3-7, 2003.
40. R. İdilman, C. Üstün, S. Karayalçın, A. Aktemel, AR Türkyılmaz, M. Özcan, Ö. Arslan, AM. Bozdayı, DH. Van Thiel, H. Akan. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation. Clin Transplant 17: 1-6, 2003
41. M. Beksaç, H. Çelebi, H. Sargın, A. Yalçın, P. Topçuoğlu, S. Kalayoğlu-Beşışık, C. Beyan, Ö. Arslan, M. Özcan, G. Gürman, O. İlhan, H. Akan. Role of pretransplantinterferon-alpha (IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogeneous leukemia (CML): results from three Turkish transplant centers. Bone Marrow Transplant 31; 897-904, 2003
42. Ö. Arslan. HEMOSOFT; A new software for blood bank and apheresis management. Transfusion and Apheresis Science, 2003 (in press)
43. M. Bektas, O. Metin, O. Erkan, A.R. Turkyılmaz, D. Ibrahimoglu, B. Nas, K. Dalva, F. Akbiyik, S. Gurel, A.M. Bozdayi, C. Akay, A. Ozden, C. Yurdaydin, Ö. Arslan, O. Uzunalimoglu, H. Bozkaya. Screening for hemochromatosis in Turkey. Digestive Disease and Sciences 2003 (in press)
44. M. Arat , Ö. Arslan, G. Gürman, K. Dalva, M. Ozcan, A. Ugur, O. Ilhan.The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy. Transfusion and Apheresis Science 2003 (in press).
45. Bozkaya H, Bektas M, Metin O, Erkan O, Ibrahimoglu D, Dalva K, Akbiyik F, Gurel S, Bozdayi AM, Akay C, Yurdaydin C, Arslan O, Uzunalimoglu O. Screening for hemochromatosis in Turkey. Dig Dis Sci. 2004 Mar;49(3):444-9.
46. Idilman R, Arat M, Soydan E, Törüner M, Soykan I, Akbulut H, Arslan O, Ozcan M, Türkyilmaz AR, Bozdayi M, Karayalçin S, Van Thiel DH, Ozden A, Beksaç M, Akan H. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat. 2004 Mar;11(2):141-7.
47. Ö. Arslan, İ. Tek, M. Arat, İ. Çiftçi, O. İlhan. Effects of replacement fluids on plasma viscosity used for therapeutic plasma exchange. Ther Apher Dial. 2004 Apr;8(2):144-7.
48. Arslan O, Toprak S, Arat M, Kayalak Y. Hb content-based transfusion policy successfully reduces the number of RBC units transfused. Transfusion. 2004 Apr;44(4):485-8.
49. Demirer T, Ayli M, Fen T, Ozcan M, Arat M, Buyukberber S, Arslan O, Gurman G, Akan H, Ilhan O. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluation. Bone Marrow Transplant. 2004 Nov;34(9):781-6.
50. Tek I, Arslan O, Arat M, Ayyildiz E, Tol M, Oral M, Ilhan O. Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure.
Transfus Apher Sci. 2004 Oct;31(2):89-93.
51. Arslan O. Haemovigilance in developing countries.
Hematology. 2005;10 Suppl 1:79-81. Review.
52. Arslan O. Donors' blood group declaration before donation can be used as a tool for electronic crossmatching. Transfus Med. 2005 Dec;15(6):487-92.
53. Arslan O. Electronic crossmatching.
Transfus Med Rev. 2006 Jan;20(1):75-9.
54. Akan H, Arslan O, Akan OA. Tuberculosis in stem cell transplant patients.
J Hosp Infect. 2006 Apr;62(4):421-6.
55. Bakanay SM, Dalva K, Arat M, Arslan O, Ayyildiz E, Beksac M, Ilhan O. Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest? Transfus Apher Sci. 2006 Apr;34(2):171-8.
56. Yücesan C, Arslan O, Arat M, Yücemen N, Ayyildiz E, Ilhan O, Mutluer N. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases. Transfus Apher Sci. 2007 Feb;36(1):103-7.
57. Ayyildiz E, Arslan O, Topçuoğlu P, Arat M, Dalva K, Soydan EA, Tol M, Ilhan O. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD). Transfus Apher Sci. 2007 Feb;36(1):79-85.
58. Büyükkağnici DI, Ilhan O, Kavas GO, Arslan O, Arat M, Dalva K, Ayyildiz E. Effects of plasma nitric oxide levels on platelet activation in single donor apheresis and random donor concentrates. Transfus Apher Sci. 2007 Feb;36(1):73-8.
59. Gürak S, Arslan O. Efficacy of Fenwal Amicus blood cell separator in double dose platelet collection. Transfus Apher Sci. 2007 Feb;36(1):69-72.
60. Arslan O. Turkish Hemapheresis Society activity for 2005.
Transfus Apher Sci. 2007 Feb;36(1):55.
61. Topcuoglu P, Akcaglayan Soydan E, Ekiz F, Ayyildiz E, Dalva K, Ozcan M, Arslan O, Arat M, Ilhan O. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight. Transfus Apher Sci. 2007 Jun;36(3):275-80.
62. Soydan E, Ayyıldız E, Dalva K, Topçuoğlu P, Tol M, Arslan O, Ilhan O, Arat M. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra. Transfus Apher Sci. 2007 Jun;36(3):269-273.
63. Arslan O, Arat M. Apheresis information management system (AMIS).
Transfus Apher Sci. 2007 Jun;36(3):281-3.
64. Arslan O. Whole blood donor deferral rate and characteristics of the Turkish population.
Transfus Med. 2007 Oct;17(5):379-83.
65. Arslan O, Moog R. Mobilization of peripheral blood stem cells.
Transfus Apher Sci. 2007 Oct;37(2):179-85.
Üye Oldugu Mesleki Kuruluş ve Organizasyonlar
American Socıety of hematology
Türk Hematoloji Derneği
Hemaferez Derneği
European Socıety for hemapheresis
European Socıety of Hematology